Cangrelor Monotherapy Bridging for Cardiac and Non-Cardiac Surgery Following Percutaneous Coronary Intervention

Turk Kardiyol Dern Ars. 2025 Mar;53(2):143-147. doi: 10.5543/tkda.2024.86987.

Abstract

Managing dual antiplatelet therapy (DAPT) perioperatively is challenging, especially in patients who have recently undergone percutaneous coronary intervention (PCI). Intravenous antiplatelet agents are recommended in these cases. This case series describes the perioperative management of two high bleeding risk patients with recent PCI undergoing cardiac and non-cardiac surgeries using cangrelor monotherapy.

Publication types

  • Case Reports

MeSH terms

  • Adenosine Monophosphate* / administration & dosage
  • Adenosine Monophosphate* / analogs & derivatives
  • Adenosine Monophosphate* / therapeutic use
  • Aged
  • Female
  • Humans
  • Male
  • Middle Aged
  • Percutaneous Coronary Intervention* / methods
  • Platelet Aggregation Inhibitors* / administration & dosage
  • Platelet Aggregation Inhibitors* / therapeutic use

Substances

  • cangrelor
  • Adenosine Monophosphate
  • Platelet Aggregation Inhibitors